51. Three‐Pronged Attack by Homologous Far‐red/NIR AIEgens to Achieve 1+1+1>3 Synergistic Enhanced Photodynamic Therapy
- Author
-
Dong Wang, Wenhan Xu, Zhihan Zhang, Jing‐Jun Nie, Fu-Jian Xu, Ben Zhong Tang, Jacky W. Y. Lam, Michelle M. S. Lee, and Ryan T. K. Kwok
- Subjects
Organelles ,Luminescent Agents ,Photosensitizing Agents ,Biological studies ,Infrared Rays ,010405 organic chemistry ,Chemistry ,medicine.medical_treatment ,Photodynamic therapy ,General Chemistry ,010402 general chemistry ,01 natural sciences ,Catalysis ,0104 chemical sciences ,Photochemotherapy ,medicine ,Biophysics ,Humans ,Aggregation-induced emission ,Reactive Oxygen Species ,HeLa Cells - Abstract
Photodynamic therapy (PDT) has long been shown to be a powerful therapeutic modality for cancer. However, PDT is undiversified and has become stereotyped in recent years. Exploration of distinctive PDT methods is thus highly in demand but remains a severe challenge. Herein, an unprecedented 1+1+1>3 synergistic strategy is proposed and validated for the first time. Three homologous luminogens with aggregation-induced emission (AIE) characteristics were rationally designed based on a simple backbone. Through slight structural tuning, these far-red/near-infrared AIE luminogens are capable of specifically anchoring to mitochondria, cell membrane, and lysosome, and effectively generating reactive oxygen species (ROS). Notably, biological studies demonstrated combined usage of three AIE photosensitizers gives multiple ROS sources simultaneously derived from several organelles, which gives superior therapeutic effect than that from a single organelle at the same photosensitizers concentration. This strategy is conceptually and operationally simple, providing an innovative approach and renewed awareness of improving therapeutic effect through three-pronged PDT.
- Published
- 2020
- Full Text
- View/download PDF